Trial intelligence / Profile preview

Azithromycin and Cefixime for Typhoid Fever in South Asia

NCT04349826Phase 4Completed

Sponsor
Oxford University Clinical Research Unit
Start
May 2021
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of cefixime in typhoid fever, paratyphoid fever, sponsored by Oxford University Clinical Research Unit. Started May 2021; status: completed.

02

Drugs

cefixime
03

Conditions

typhoid feverparatyphoid fever

Beyond the preview

Go deeper on NCT04349826.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04349826.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call